Assignee

INSIGNIS THERAPEUTICS INC

US2 patents

Top patents by PatentIndex Score

US11213484B2Jan 4, 2022

Dipivefrin orally disintegrating tablet formulations

INSIGNIS THERAPEUTICS INC0 citations57

US11213496B2Jan 4, 2022

Methods of using dipivefrin

INSIGNIS THERAPEUTICS INC0 citations57